MyoKardia Surges After Heart Drug Clears Late-Stage Hurdle

(Bloomberg) -- MyoKardia Inc. jumped on Monday after its experimental treatment for a rare heart condition met its primary goal and all secondary targets in a key study, delivering a win for the no...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.